Subject-Exoskeleton Contact Model Calibration Leads to Accurate Interaction Force Predictions.


Journal

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
ISSN: 1558-0210
Titre abrégé: IEEE Trans Neural Syst Rehabil Eng
Pays: United States
ID NLM: 101097023

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 28 6 2019
medline: 19 5 2020
entrez: 28 6 2019
Statut: ppublish

Résumé

Knowledge of human-exoskeleton interaction forces is crucial to assess user comfort and effectiveness of the interaction. The subject-exoskeleton collaborative movement and its interaction forces can be predicted in silico using computational modeling techniques. We developed an optimal control framework that consisted of three phases. First, the foot-ground (Phase A) and the subject-exoskeleton (Phase B) contact models were calibrated using three experimental sit-to-stand trials. Then, the collaborative movement and the subject-exoskeleton interaction forces, of six different sit-to-stand trials were predicted (Phase C). The results show that the contact models were able to reproduce experimental kinematics of calibration trials (mean root mean square differences - RMSD - coordinates ≤ 1.1° and velocities ≤ 6.8°/s), ground reaction forces (mean RMSD≤ 22.9 N), as well as the interaction forces at the pelvis, thigh, and shank (mean RMSD ≤ 5.4 N). Phase C could predict the collaborative movements of prediction trials (mean RMSD coordinates ≤ 3.5° and velocities ≤ 15.0°/s), and their subject-exoskeleton interaction forces (mean RMSD ≤ 13.1° N). In conclusion, this optimal control framework could be used while designing exoskeletons to have in silico knowledge of new optimal movements and their interaction forces.

Identifiants

pubmed: 31247556
doi: 10.1109/TNSRE.2019.2924536
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1597-1605

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH